viernes, 16 de octubre de 2020

The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study | The Journal of Headache and Pain | Full Text

The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study | The Journal of Headache and Pain | Full Text

We evaluated the efficacy of fremanezumab, a fully humanized monoclonal antibody that selectively targets calcitonin gene-related peptide, in patients with chronic migraine (CM) with and without medication ove...
Authors:Stephen D. Silberstein, Joshua M. Cohen, Michael J. Seminerio, Ronghua Yang, Sait Ashina and Zaza Katsarava
Citation:The Journal of Headache and Pain 2020 21:114
Content type:Research article
 
Published on: 

No hay comentarios:

Publicar un comentario